The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022Phase 1b Trial to Assess the Safety and Efficacy of Dopamine Cell Transplants in Parkinson’s Disease Linked to Mutations in Parkin
Study Rationale: We have shown that although cell transplants are able to produce dopamine and improve motor problems in some individuals with Parkinson’s disease (PD), differences in the quality of...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Assessing the Awareness, Perception, Diagnosis, and Treatment of Parkinson’s Disease in Africa
Study Rationale: Parkinson’s disease (PD) is little known in most parts of Africa and its symptoms are often ascribed to normal aging or to an unknown disorder. Most health care facilities lack the...
-
Fall 2021 RFP: Outcome Measures, 2022Use of Integrated, Multi-omic Data Analysis for Screening and Treatment of Parkinson’s Disease
Study Rationale: Current diagnostic criteria and treatment options are designed for the “average” person with Parkinson’s disease (PD). This one-size-fits-all approach ignores the huge biological and...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Engaging the LGBTQIA+ Community, Caregivers and Care Providers in Research on Living with Parkinson’s Disease
Study Rationale: Four million LGBTQIA+ adults age 50 and above live in the United States. We know very little about the needs of those in the LGBTQIA+ community who are living with Parkinson’s disease...
-
, 2022The Heads-Up Trial: Exploring the Effects of Sleeping in a Head-up Tilt Position on Blood Pressure in Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) affects the function of the autonomic nervous system, which controls blood pressure (BP), often resulting in both a low BP upon rising (orthostatic...
-
Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022Development of Immune-based Biomarkers for Parkinson’s Disease
Study Rationale: Preclinical and human studies have demonstrated the potential of using granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of Parkinson’s disease (PD). GM-CSF...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.